Last reviewed · How we verify

NCT04607525

Dexmedetomidine Infusion Effect on Hemodynamic Variables During Craniotomy

Completed Phase 4 Last updated 1 March 2021
What this trial tests

Phase 4 trial testing Dexmedetomidine in Hemodynamic Instability in 40 participants. Completed in 26 January 2021.

Timeline
21 November 2020
Primary endpoint
20 January 2021
26 January 2021

Quick facts

Lead sponsorAin Shams University
PhasePhase 4
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposeprevention
Enrollment40
Start date21 November 2020
Primary completion20 January 2021
Estimated completion26 January 2021
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Ain Shams University

Who can join

Adults 18 to 65, any sex, with Hemodynamic Instability or Supratentorial Neoplasms. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

There is no clear consensus among neuroanesthesiologists regarding which anesthetic regimen is optimal for craniotomy. Propofol and short-acting opioids (such as remifentanil, fentanyl, or sufentanil) are commonly used. However, use of opioids is associated with increased risk of respiratory depression and postoperative nausea and vomiting. Dexmedetomidine is a highly selective α2-adrenoreceptor agonist that has been considered as a useful and safe adjunct to anesthesia for various surgical procedures

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Efficacy of Dexmedetomidine Infusion Without Loading Dose on Hemodynamic Variables and Recovery Time During Craniotomy: A Randomized Double-blinded Controlled Study.
    Ibrahim IM, Hassan R, Mostafa RH, Ibrahim MA. · · 2021 · cited 10× · PMID 34336625 · DOI 10.5812/aapm.113410

Verify or expand the search:

Other trials of Dexmedetomidine

Trials testing the same drug.

Other recruiting trials for Hemodynamic Instability

Currently open trials in the same condition.

Other Ain Shams University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04607525.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing